Pharmacoepidemiology and Benefit-Risk Management

PrimeVigilance’s multi–disciplinary team is led by Dr. Michael Forstner, Head of Pharmacoepidemiology and Risk Management.

As a well-known and respected expert in the design and implementation of evidence based studies, along with cutting-edge methods in both pharmacovigilance planning and risk management, PrimeVigilance is a unique industry partner.

PrimeVigilance’s researchers bring hundreds of years of experience from industry, regulatory authorities, and academia in all important therapeutic areas, as well as advanced degrees in medicine, pharmacoepidemiology, biostatistics, pharmacology, and public health to the table to provide expert advice in all areas of pharmacoepidemiology and pharmacovigilance benefit/risk management. PrimeVigilance can support you in specific short-term projects or through extended arrangements with dedicated experts on a long-term basis.